Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 5
2008 9
2009 20
2010 22
2011 39
2012 42
2013 50
2014 72
2015 69
2016 74
2017 70
2018 63
2019 65
2020 49
2021 60
2022 31
2023 34
2024 29
2025 25
2026 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

739 results

Results by year

Filters applied: . Clear all
Page 1
Clinical applications of the CellSearch platform in cancer patients.
Riethdorf S, O'Flaherty L, Hille C, Pantel K. Riethdorf S, et al. Adv Drug Deliv Rev. 2018 Feb 1;125:102-121. doi: 10.1016/j.addr.2018.01.011. Epub 2018 Feb 2. Adv Drug Deliv Rev. 2018. PMID: 29355669 Review.
The CellSearch system (CS) enables standardized enrichment and enumeration of circulating tumor cells (CTCs) that are repeatedly assessable via non-invasive "liquid biopsy". While the association of CTCs with poor clinical outcome for cancer patients has cle …
The CellSearch system (CS) enables standardized enrichment and enumeration of circulating tumor cells (CTCs) that are repeate …
Filtration based assessment of CTCs and CellSearch based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H, Fasching PA, Gumbrecht W, Jud S, Rauh C, Matzas M, Paulicka P, Friedrich K, Lux MP, Volz B, Gass P, Häberle L, Meier-Stiegen F, Hartkopf A, Neubauer H, Almstedt K, Beckmann MW, Fehm TN, Ruebner M. Huebner H, et al. BMC Cancer. 2018 Feb 20;18(1):204. doi: 10.1186/s12885-018-4115-1. BMC Cancer. 2018. PMID: 29463222 Free PMC article.
Overall survival (OS) was calculated and Kaplan-Meier curves were estimated with thresholds of 1 and 5 detected CTCs. RESULTS: The CTC positivity rate of the CellSearch system was 56.7% and of the filtration-based platform 66.7%. ...The median OS of patients with …
Overall survival (OS) was calculated and Kaplan-Meier curves were estimated with thresholds of 1 and 5 detected CTCs. RESULTS: The …
CTCs in metastatic breast cancer.
Giordano A, Cristofanilli M. Giordano A, et al. Recent Results Cancer Res. 2012;195:193-201. doi: 10.1007/978-3-642-28160-0_18. Recent Results Cancer Res. 2012. PMID: 22527507 Review.
Circulating tumor cells (CTCs), enumerated by the Food and Drugs Administration-cleared CellSearch( ) system, are an independent prognostic factor of progression-free survival (PFS) and overall survival (OS) in metastatic breast cancer (MBC) patients. ...Randomized …
Circulating tumor cells (CTCs), enumerated by the Food and Drugs Administration-cleared CellSearch( ) system, are an independe …
Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells.
Wang L, Balasubramanian P, Chen AP, Kummar S, Evrard YA, Kinders RJ. Wang L, et al. Semin Oncol. 2016 Aug;43(4):464-75. doi: 10.1053/j.seminoncol.2016.06.004. Epub 2016 Jun 15. Semin Oncol. 2016. PMID: 27663478 Free PMC article. Review.
We discuss the use of CellSearch (Janssen Diagnostics, LLC, Raritan, NJ) CTC isolation technology for monitoring PD response in early phase trials. ...Overall, the level of phenotypic heterogeneity observed in specimens from patients with advanced carcinomas suggests cauti …
We discuss the use of CellSearch (Janssen Diagnostics, LLC, Raritan, NJ) CTC isolation technology for monitoring PD response in early …
Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer.
Huang X, Gao P, Song Y, Sun J, Chen X, Zhao J, Xu H, Wang Z. Huang X, et al. BMC Cancer. 2015 Mar 30;15:202. doi: 10.1186/s12885-015-1218-9. BMC Cancer. 2015. PMID: 25880692 Free PMC article.
BACKGROUND: The prognostic value of circulating tumor cells (CTCs) detected with the CellSearch System in patients with colorectal cancer (CRC) is controversial. ...CONCLUSIONS: Our meta-analysis indicates that the detection of CTCs in the peripheral blood wi …
BACKGROUND: The prognostic value of circulating tumor cells (CTCs) detected with the CellSearch System in patients with colore …
Immunomagnetic separation technologies.
Hoeppener AE, Swennenhuis JF, Terstappen LW. Hoeppener AE, et al. Recent Results Cancer Res. 2012;195:43-58. doi: 10.1007/978-3-642-28160-0_4. Recent Results Cancer Res. 2012. PMID: 22527493 Review.
The largest difficulty one faces in the development of technology for detection of circulating tumor cells (CTCs) is whether or not tumor cells are present in the blood and at what frequency. Although the introduction of the validated CellSearch system for CTC enume …
The largest difficulty one faces in the development of technology for detection of circulating tumor cells (CTCs) is whether or not t …
Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).
Bahnassy AA, Salem SE, Mohanad M, Abulezz NZ, Abdellateif MS, Hussein M, Zekri CAN, Zekri AN, Allahloubi NMA. Bahnassy AA, et al. Exp Mol Pathol. 2019 Feb;106:90-101. doi: 10.1016/j.yexmp.2018.12.006. Epub 2018 Dec 19. Exp Mol Pathol. 2019. PMID: 30578762
PURPOSE: We assessed CTCs counts in NMCRC patients using four different techniques. METHODS: CTCs were detected in 63 NMCRC patients, 40 benign bowel diseases (BBD) and 40 normal controls (NC) using, flow-cytometry (FCM), CellSearch (CS), cytomorphology and q …
PURPOSE: We assessed CTCs counts in NMCRC patients using four different techniques. METHODS: CTCs were detected in 63 NMCRC pa …
Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System.
Truini A, Alama A, Dal Bello MG, Coco S, Vanni I, Rijavec E, Genova C, Barletta G, Biello F, Grossi F. Truini A, et al. Front Oncol. 2014 Sep 4;4:242. doi: 10.3389/fonc.2014.00242. eCollection 2014. Front Oncol. 2014. PMID: 25237652 Free PMC article. Review.
Circulating tumor cells (CTCs) are cells spread from the primary tumor into the bloodstream that might represent an important biomarker in lung cancer. ...So far, the CellSearch( ) system is the only approach approved by FDA for metastatic breast, prostate, and colo …
Circulating tumor cells (CTCs) are cells spread from the primary tumor into the bloodstream that might represent an important biomark …
Circulating tumor cell enumeration by the CellSearch system: the clinician's guide to breast cancer treatment?
Beije N, Jager A, Sleijfer S. Beije N, et al. Cancer Treat Rev. 2015 Feb;41(2):144-50. doi: 10.1016/j.ctrv.2014.12.008. Epub 2014 Dec 23. Cancer Treat Rev. 2015. PMID: 25542852 Review.
Circulating tumor cells (CTCs) are cancer cells that are present in the blood of patients with solid cancers and are shed from existing tumor lesions into the blood stream. The enumeration of CTCs has long been considered to hold great promise in guiding treatment d …
Circulating tumor cells (CTCs) are cancer cells that are present in the blood of patients with solid cancers and are shed from existi …
Circulating Tumor Cells in Breast Cancer.
Liang DH, Hall C, Lucci A. Liang DH, et al. Recent Results Cancer Res. 2020;215:127-145. doi: 10.1007/978-3-030-26439-0_7. Recent Results Cancer Res. 2020. PMID: 31605227 Review.
Here, we review the clinical significance of CTCs, as detected by the FDA-approved CellSearch( ) System, in both metastatic and non-metastatic breast cancer patients. Studies so far suggest that CTCs are prognostic of poorer outcomes in breast cancer patients …
Here, we review the clinical significance of CTCs, as detected by the FDA-approved CellSearch( ) System, in both metastatic an …
739 results